Click to Share
 
 
  1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

drug development Press Releases

  + XML/RSS  



By Rosa & Co
Dr. Schoeberl will present “Using Mathematical Models To Set Design Criteria For Antibody-Based Therapies” April 17, 2012.

By Cambridge Healthtech Institute
Those that missed last month's event can get a CD with 350 speaker presentations from 16 conferences within 4 scientific channels: diagnostics, drug discovery & development, informatics and cancer. TriConference.com

By Rosa & Co
Series of Seminars and Workshops to be held in 2012 across the US and in Europe

By Impuls Public Relations OG
Vela Laboratories and Anagnostics enter strategic partnership to offer hybcell technology to biotech and pharma customers under GMP conditions.

By Cambridge Healthtech Institute
Join us for a roundtable discussion during the Cancer Biologics Conference at the Tri-Conference. Discussion moderated by: Norman J. Maitland, Ph.D., Chief Scientific Officer, Procure Therapeutics Ltd.

By Biopontis Alliance
Collaboration will combine Rosa’s PhysioPD™ modeling & simulation capabilities with Biopontis’ innovative asset sourcing and financial structure to improve early drug development productivity

By Cambridge Healthtech Institute
A roundtable discussion during the Cancer Biologics Conference at the Tri-Conference. Moderated by: Ho Sung Cho, Ph.D., Chief Technical Officer, Ambrx.

By Cambridge Healthtech Institute
A roundtable discussion during the Cancer Biologics Conference at the Tri-Conference. Moderatored by: Gary Starling, Ph.D., Director, GPRD Discovery, Oncology Biologics, Abbott Biotherapeutics Corp.

By Cambridge Healthtech Institute
CHI’s Cancer Biologics conference is a 3-day event based on in-depth research with experts in the field.

By ValueNotes
Recently published research shows a major shift in global pharmaceutical companies outsourcing core research and development (R&D) services such as drug development and clinical trials through strategic third-party collaborative partnerships.

By Cambridge Healthtech Institute
Hear Drug Discovery Leaders at the Upcoming Molecular Medicine Tri-Conference

By ReportsnReports
Business Insight’s new report “New Emerging R&D Locations” is now available at ReportsnReports.com.

By Cambridge Healthtech Institute
Delegates now have the option to choose from 3 moderated breakout discussion groups at this conference that is set for February 21-23, San Francisco, CA (part of CHI's Molecular Med TRI-CON 2012).

By ReportsnReports
Espicom Limited’s new report “Evolution in the Pain Therapy Drugs Market : Nociceptive and Neuropathic Drug Development” is now available at ReportsnReports.com.

By Camrbridge Healthtech Institute
Cambridge Healthtech Institute's 8th Annual Translational Science Event Only 7 Weeks Away! Advance Registration Discount expires Friday, January 13th!

By ReportsnReports
Kalorama Information’s new report “Outsourcing in Drug Development: The Contract Research (Clinical Trials) Market” is now available at ReportsnReports.com.

By SMi Group
Paediatric vaccine development: Some key clinical trials - their design, execution and ethics

By Rosa & Co
Integration Creates Seamless Data Management and Analysis Capability for ARA Customers

By Reportsnreports
Business Monitor International ‘s “Global Clinical Trial Market (2007 - 2010) (Key Therapeutic Categories, Country Wise Metrics & Regulatory Approval Framework)” is now available at ReportsnReports.com.

By Melbourn Scientific
New award at DDL22 recognises the contribution of young people to the pharmaceutical industry.

By Ashley Rowe
IQPC’s 7th Annual Compound Management & Integrity Summit brings together Pharmaceutical Professionals, Clinical Research Organizations and Industry Experts to address evolving industry concerns

By Compliance2go.com
Holders of the IND for new products i.e. the Sponsors. Also, Principal Investigators and sub investigators, Clinical Research Scientists Safety Nurses, Clinical Research Associates and Coordinators , Recruiting staff, QA / QC auditors and staff.

By SMi Group Ltd
SMi Group is proud to announce its 10th annual Clinical Trials in CNS conference, which will be held in London on 23rd & 24th November 2011.

By Ashley Rowe
IQPC’s Pharmacovigilance North America Summit brings together industry experts to address top industry concerns

By SMi Group
Biobanking - Collaborating for Global R&D and Investment 11th & 12th July 2011 Crowne Plaza - The City, London, UK

By Luminovas
Niiki Pharma will present Phase I clinical study data for its transferrin targeted ruthenium based anti-cancer compound, NKP-1339, at the 2011 American Society for Clinical Oncology meeting in Chicago, IL.

By Stephanie Flynn
Galera Therapeutics today announced Dr. Robert (Al) Beardsley as its new Chief Executive Officer.

By Dave Karasic, J.D.
The Boston-area formulation development CRO Integral BioSystems, LLC announces tradeshow presence at key pharmaceutical and biotech conferences, as part of its strategy to increase visibility.

By Cambridge Healthtech Institute
Cambridge Healthtech Institute announces two of the largest molecular imaging societies are sponsoring its In Vivo Molecular Imaging in Drug Discovery & Development event on June 8 – 9, in Philadelphia, as part of its World Pharma Congress.

By Rosa & Co
Alliance combines innovative exploratory study design, leading in silico drug development capabilities, and a global licensing network to increase the value of emerging company portfolios and address pipeline gaps for established drug manufacturers.

By SMi Group
Discuss with top the 50 pharma companies how to manage various types of pain through drugs and the development of new promising drugs from conception to clinical testing.

By SMi Group
Regulatory options for generics through different licensing possibilities and regulatory chalenges while working in MENA will be discussed by top 50 pharma companies

By Cambridge Healthtech Institute
75 Speaker presentations are available on CD from Cambridge Healthtech Institute’s past event, SCOPE: Summit for Clinical Ops Executives, which took place on February 7-9, 2011 in Miami, FL.

By BioAtla
BioAtla and Charles River have partnered to create an integrated biological service for antibodies and other protein therapeutics designed to accelerate drug development for customers from the earliest stages of discovery all the way through IND.

By SMi Group
With biobank collections increasing in value by medical researchers and drug developers worldwide, the biobank market is enjoying rapid growth in the number of national biobanks and efforts to build co-operative networks between them globally.

By SMi Group
Identify the key issues responsible for the low success rates in CNS drug discovery and development, to highlight strategies being developed to overcome these issues and to discuss how these may change the landscape for drug development.

By Menzies Consulting, Inc.
Company Leasing New Office Space, Increasing Workforce

By Q1 Productions
Ensuring a Cohesive Scientific and Business Approach to Early-Phase Clinical Research to Ensure the Development of Safe & Effective New Therapies

By Insight Pharma Reports
Nuclear Receptors: The Pipeline Outlook Report

By SMi Group
Therapeutic antibodies are central to pharmaceutical development; needless to say, emphasis is continually on developing new methods and improving those already in place. Play an active role in the war against disease – register online today!

By SMi Group
This workshop will look at how to negotiate the pharmaceutical minefield that is the counterfeit threat, how to identify what will really work for you and your brand and how to stay one step ahead of the counterfeiters.

By SEOP, Inc.
In line with its premium on quality, speed and thoroughness for its drug development services, UPM Pharmaceuticals keeps its technology up-to-date. Its most recent acquisition improves the company's pharmaceutical powder processing.

By SEOP, Inc.
UPM Pharmaceuticals, the drug development expert, has been providing its invaluable services to the pharmaceutical industry for more than a decade. The company maintains a state-of-the-art manufacturing facility in Baltimore.

By SEOP, Inc.
UPM Pharmaceuticals is a recognized leader in the drug development industry. The company leverages its expertise to assist pharmaceutical clients with all concerns related to medicine development.

By SMi Group Ltd.
This masterclass will examine the solubility and supersaturation of drugs from a solution chemistry point of view. We will explain how solubility is affected by molecular structure, pH, pKa and salt formation, and discuss the role of lipophilicity.

By SMi Group Ltd.
10th September 2010, Millenium Gloucester Hotel, London, UK A CPD accredited SMi Pharma-Masterclass focusing on various issues concerning Data Management in Medical Imaging

By SMi Group Ltd.
Attend this CPD Accredited Masterclass to get a better understanding of the application of epigenetic profiling to pharmaceutical development. Appreciating the potential of such techniques could result in brilliant advances in life saving technology.

By Agnes Shanley
The drug industry continues to face consent decrees and enforcement actions. In a free webcast on July 22 at 11 AM ET, former FDA scientist Ali Afnan and a panel of experts explore why pharma's quality systems are failing to evolve, and solutions.

By MarketResearch.com
MarketResearch.com has added a new report, “Stakeholder Opinions: Melanoma Future treatment will be based on individual tumor gene expression signatures,” which focuses on current melanoma issues and developing treatment methods.

By Pharmaceutical Manufacturing Magazine
Leading drug industry experts speak on tweaking Toyota methods to improve laboratory cycle time and efficiency.




Page updated every 10 minutes


  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Service
  5. Copyright Notice
  6. About
  7. Advertise
Like PRLog?
9K2K1K
Click to Share